Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol FGF1 contributors: mct/pgu - updated : 12-04-2016
HGNC name fibroblast growth factor 1 (acidic)
HGNC id 3665
PROTEIN
PHYSICAL PROPERTIES
STRUCTURE
motifs/domains
  • N-terminal nuclear localization signal (NLS) implicated in the stimulation of DNA synthesis
  • two nuclear localization signals required for transport from the cytosol to the nucleus of externally added FGF-1 translocated into cells
  • a second putative NLS (NLS2), near the C-terminus,(a bipartite NLS consisting of two clusters of lysines separated by a spacer of 10 amino acids)
  • a IL1B-like domain
  • implication of FGF1 C-terminal domain on its intracellular activities
  • HOMOLOGY
    interspecies homolog to murine Fgf1 (95.5pc)
    homolog to rattus Fgf1 (95.5pc)
    Homologene
    FAMILY
  • heparin-binding growth factors family
  • fibroblast growth factor (FGF) family
  • CATEGORY protooncogene , signaling growth factor
    SUBCELLULAR LOCALIZATION extracellular
        plasma membrane
        intracellular
    intracellular,cytoplasm,cytosolic
    intracellular,nucleus,nucleoplasm
    intracellular,nucleus,nucleolus
    text
  • phosphorylation occurs normally in the nucleus, and both NLS1 and NLS2 are important for efficient transport to the nucleus
  • under stress, FGF1 and S100A13 colocalize at the plasma membrane
  • upon stress, FGF1 is transported to the plasma membrane where it localizes prior to transmembrane translocation
  • basic FUNCTION
  • heparin binding growth factor
  • functioning as a modifier of endothelial cell migration and proliferation, as well as an angiogenic factor and mitogen for a variety of mesoderm- and neuroectoderm cells
  • involved in organogenesis, in cardiomyocyte proliferation and angiogenesis during development
  • perichondrial FGF1, FGF2, FGF6, FGF7, FGF9, FGF18, FGF21, fGF22 regulate growth plate chondrogenesis
  • potent inducer of cell migration and chemotaxis
  • activates spinal astrocytes, and activated astrocytes are implicated in neurodegenerative disorders such as amyotrophic lateral sclerosis
  • involved in opening pannexin and connexin hemichannels
  • stress-induced unconventional export of FGF1, is associated with and dependent on the formation of membrane blebs and localized cell surface exposure of phosphatidylserine
  • metabolic role for FGF1 as a critical transducer of PPARG signalling that mediates the proper coupling of nutrient storage to adaptive remodelling of adipose tissue
  • FGF1 and FGF2 play a critical role in angiogenesis, a formation of new blood vessels from existing blood vessels
  • induces maturation and cell cycle exit in chondrocytes, triggers rapid accumulation of RBL1-PPP2R2A complexes coinciding with RBL1 dephosphorylation
  • prolonged biological activity of FGF1 can be achieved by increasing its proteolytic resistance directly linked to improved global thermostability
  • acts through cell surface tyrosine kinase receptors, but FGF1 can also act directly in the cell nucleus, as a result of nuclear import of endogenously produced, non-secreted FGF1 or by transport of extracellular FGF1 via endosomes and cytosol into the nucleus
  • antidiabetes function of FGF1 may act partially through increasing beta-cell differentiation
  • role of intracellular FGF1 is to protect the cell against stress conditions by providing an additional signal for cell survival, independently of receptor-activated signaling cascades
  • lacking a secretion peptide signal and acting mainly in an intracellular and nuclear manner
  • CELLULAR PROCESS
    PHYSIOLOGICAL PROCESS
    PATHWAY
    metabolism
    signaling
    a component
  • PPARG-FGF1 axis is critical for maintaining metabolic homeostasis and insulin sensitization
  • Heparan sulfate (HS) chains form ternary complexes with FGF1/FGFR when enzymes carry out modifications in a specific manner
  • INTERACTION
    DNA
    RNA
    small molecule
    protein
  • associated with S100A13 and p40 extracellular domain of synaptotagmin 1 (SYT1) for the release of signal peptide-less FGF1 in a temperature stress-induced pathway
  • directly interacts with integrins in a dose-dependent manner (with ITGAV)
  • interacting with S100A13 (released from the cells as a copper-dependent multiprotein complex that includes a small calcium-binding protein S100A13)
  • induces regulated intramembrane proteolysis (RIP) of FGFR3
  • both FGF19 and FGF21 but not FGF1 exhibit binding affinity to KLB
  • KPNA1, KPNB1 were required for nuclear import of FGF1
  • LRRC59 is strictly required for nuclear import of exogenous FGF1
  • nucleolin (NCL), a nuclear multifunctional protein, is an interaction partner of FGF1, and NCL-FGF1 interaction is critical for the intranuclear phosphorylation of FGF1 by PRKCD and thereby the regulation of nuclear export of FGF1
  • direct interaction of CTGF and FGF1, suggesting the co-presence of these molecules in the cartilage microenvironment
  • BGN binds to FGFR3c and FGF1
  • in heat-shocked cells, FGF1 and the C-terminal fragment of AHNAK2 colocalized with F-actin in the vicinity of the cell membrane
  • cell & other
    REGULATION
    induced by temperature stress-induced pathway
    Phosphorylated by PRKCD (in the nucleus, FGF1 can be phosphorylated by PRKCD, and this event induces nuclear export of FGF1)
    Other accessible to pharmacologic regulation
    down-regulated by the binding of RFX1 to its promoter region
    induced in visceral (i.e. gonadal) white adipose tissue (WAT) in response to a high-fat diet
    phosphorylation does not regulate FGF1 neurotrophic activity but inhibits its anti-apoptotic activity after TP53-dependent apoptosis induction
    ASSOCIATED DISORDERS
    corresponding disease(s)
    Other morbid association(s)
    TypeGene ModificationChromosome rearrangementProtein expressionProtein Function
    constitutional       loss of function
    results in diet-induced insulin resistance
    Susceptibility
  • to intracranial aneurysm
  • to Alzheimer disease(AD)
  • to variation of systolic Blood pressure
  • Variant & Polymorphism SNP
  • SNP at intron 4 increasing the risk of intracranial aneurysm
  • promoter polymorphism (-1385 A/G) was significantly associated with AD risk
  • SNP rs152524 was associated in a dose-dependent manner with systolic Blood pressure
  • Candidate gene
    Marker
    Therapy target
    SystemTypeDisorderPubmed
    cancer  
    mutant R50E suppressed tumor growth while WT FGF1 enhanced it using cancer cells that stably express WT FGF1 or R50E
    cardiovascularatheroma 
    FGF1/MAPK14 inhibitor therapy induces cardiomyocyte mitosis, reduces scarring, and rescues function after myocardial infarction
    ANIMAL & CELL MODELS
  • Fgf1 is highly induced in adipose tissue in response to high-fat diet (HFD) and mice lacking Fgf1 develop an aggressive diabetic phenotype coupled to aberrant adipose expansion when challenged with HFD